FORM 4
[X] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
 OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Ugwumba Chidozie		 2. Issuer Name and Ticker or Trading Symbol

BiomX Inc. [ PHGE ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
_____ Officer (give title below)    __X__ Other (specify below)
Exit Form 4 - former 10% owner
(Last)          (First)          (Middle)

609 SW 8TH STREET, SUITE 365		 3. Date of Earliest Transaction (MM/DD/YYYY)

10/17/2022
(Street)

BENTONVILLE, AR 72712
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
 6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/17/2022  S  8098 D$0.335 3063882 (1)I By SymBiosis, LLC 
Common Stock 10/18/2022  S  15300 D$0.346 3048582 (1)I By SymBiosis, LLC 
Common Stock 10/19/2022  S  4501 D$0.367 3044081 (1)I By SymBiosis, LLC 
Common Stock 10/20/2022  S  6636 D$0.374 3037445 (1)I By SymBiosis, LLC 
Common Stock 10/21/2022  S  5400 D$0.37 3032045 (1)I By SymBiosis, LLC 
Common Stock 10/24/2022  S  5900 D$0.349 3026145 (1)I By SymBiosis, LLC 
Common Stock 10/25/2022  S  3072 D$0.365 3023073 (1)I By SymBiosis, LLC 
Common Stock 10/26/2022  S  12500 D$0.346 3010573 (1)I By SymBiosis, LLC 
Common Stock 10/27/2022  S  1505 D$0.364 3009068 (1)I By SymBiosis, LLC 
Common Stock 10/28/2022  S  1526 D$0.356 3007542 (1)I By SymBiosis, LLC 
Common Stock 10/31/2022  S  3300 D$0.371 3004242 (1)I By SymBiosis, LLC 
Common Stock 11/1/2022  S  1300 D$0.364 3002942 (1)I By SymBiosis, LLC 
Common Stock 11/2/2022  S  2416 D$0.359 3000526 (1)I By SymBiosis, LLC 
Common Stock 11/3/2022  S  2000 D$0.366 2998526 (1)I By SymBiosis, LLC 
Common Stock 11/4/2022  S  1501 D$0.378 2997025 (1)I By SymBiosis, LLC 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		8. Price of Derivative Security
(Instr. 5)		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
(1) The shares are directly held by SymBiosis, LLC.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Ugwumba Chidozie
609 SW 8TH STREET
SUITE 365
BENTONVILLE, AR 72712


Exit Form 4 - former 10% owner
Signatures
/s/ Chidozie Ugwumba11/14/2022
**Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
BiomX (AMEX:PHGE)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more BiomX Charts.
BiomX (AMEX:PHGE)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more BiomX Charts.